Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2026 08:00 ET | Source: Causeway Therapeutics Ltd

Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026

Causeway Therapeutics announces the presentation of data from its Phase 2 clinical trial evaluating TenoMiR® (CWT-001), at RNA Leaders Europe 2026.
October 28, 2025 07:00 ET | Source: Causeway Therapeutics Ltd

Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis

Causeway Therapeutics announces positive data from its Phase 2 clinical trial of TenoMiR® for lateral epicondylitis.